110 results
Page 5 of 6
6-K
EX-99
ilnm8cqj2jows
5 Jun 13
Extraordinary General Meeting of Shareholders
12:00am
6-K
EX-10.1
hcyjfpefd evtfsn0
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B5
5dovyn2
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
o7693i zczezr5v0
17 May 13
Prospectus supplement for primary offering
12:00am
424B3
qp2e2rvdh3pio 9t1
15 Oct 12
Prospectus supplement
12:00am
F-1
ewgvfih
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
g6nrbla52k
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
2r04joeazs3u
10 Sep 12
BioLineRx Announces Pre-clinical Results Demonstrating
12:00am
424B3
oenrx
2 Aug 12
Prospectus supplement
12:00am
POS AM
9q16ynl0
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
75avolui g8qc5
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
424B3
m417ihpos pviu3cxegr
28 Mar 12
Prospectus supplement
12:00am
20-F
40jx0wqvr4w5vg6
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.3
0fqwk1nlo mzap
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-99.2
dq5yycpjbhx4rmj6b
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-1
w1gd5zwqqj3x
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
20FR12B/A
naicl8jeamra6gsrx7o
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
EX-4.29
gjogu
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.5
p0p04qutjlwxw0
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am